Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

Haematologica, Vol 92, Issue 4, e49-e52 doi:10.3324/haematol.11142
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunitomi, A.
Right arrow Articles by Ishikawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunitomi, A.
Right arrow Articles by Ishikawa, T.

Online Only Articles

Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disorders presented as Interstitial Pneumonia; Successful Recovery with Rituximab

Akane Kunitomi1,, Nobuyoshi Arima1, Takayuki Ishikawa2

1 From Department of Hematology, Kitano Hospital, The Tazuke Kofukai Medical l Research Institute, Osaka, Japan
2 Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Address correspondence to: Akane Kunitomi, 2-4-20 Ohgimachi, Kita-ku, Osaka, JAPAN 530-8480, Tel: 81-6-6312-1221, Fax: 81-6-6361-0588, E-mail address: akunitom{at}kitano-hp.or.jp

We describe a patient that developed Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorders (PTLD), which presented as interstitial pneumonia. He had received allogeneic bone marrow transplantation for the treatment of acute myeloid leukemia 17 months before, when he developed hypoxemia requiring emergent admission. Chest computed tomography revealed pulmonary interstitial shadows, but neither hepatomegaly nor lymphadenopathy were detected. Bronchoscopy with lung biopsy revealed a lymphomatous proliferation of EBV-infected B cells. The interstitial pneumonia rapidly deteriorated, but improved dramatically after treatment with anti-CD20 monoclonal antibody (rituximab). This is the first report of a patient with lung EBV-PTLD that presented as interstitial pneumonia and was successfully treated with rituximab.

Key words: EBV, PTLD, rituximab, interstitial pneumonia.






HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2007 by the Ferrata Storti Foundation.